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AbstrAct
Introduction: The present article reviews findings from empirical evaluations of integrated disease management programmes. The 
objective is to provide insights on integration levels, priority interventions and their effect on patient outcomes. 
Material and Methods: The literature review identified 1 251 articles, published from 2006 to 2011. Upon a detailed screening 61 
articles were selected for bibliometric analysis and critical discussion.
results: Among several findings, it can be noted that United States of America is the country with the highest amount of published 
evidence on the subject under study. The most frequently referred disease is diabetes mellitus and the main reported issue of integrated 
disease management is self-management support. The majority of the studies were developed and exclusively managed by managed 
care organizations, organized family doctors or hospitals. From a total of 360 interventions reported in studies, patient interventions are 
the most frequently used across all disease groups, followed by professional interventions. To monitor the effectiveness of the disease 
programmes, the most frequently used outcomes are patient physiological measures, service use and patient health status.
Discussion: Every country has its own way to implement the integrated disease management strategy. The focus of practice lies on 
patient empowerment, particularly through self-management. Physiological measures and service use are the outcomes with the high-
est rate of assessment, which are also the indicators that show higher impact among all integrated disease management programmes.
conclusion: The Portuguese health care system still faces challenges in the coordination and integration of care for patients with 
chronic disease thus improvements at integrated disease management programmes should be incorporate.
Keywords: Case Management; Chronic disease; Delivery of Health Care, Integrated; Disease Management; Portugal.
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rEsUMO
Introdução: O artigo faz uma revisão de literatura sobre os programas de gestão integrada da doença, apresentando resultados sobre 
o nível de integração dos cuidados, as intervenções prioritárias utilizadas nos programas e o seu efeito, nomeadamente, nos doentes.
Material e Métodos: A revisão de literatura identificou 1 251 artigos, publicados entre 2006 e 2011. Depois de uma criteriosa seleção 
identificaram-se para a análise bibliométrica e discussão crítica, 61 artigos. 
resultados: Realçamos o facto de serem os Estados Unidos da América o país que mais publica sobre esta matéria; A doença mais 
reportada é a diabetes mellitus e o domínio de intervenção da gestão integrada da doença, predominante, é o ‘apoio ao auto-cuidado’. 
A maioria dos estudos foram implementados por managed care organizations, médicos de medicina geral e familiar organizados para 
o efeito ou hospitais. Das 360 intervenções reportadas, as mais utilizadas são as dirigidas aos doentes e aos profissionais. Os resul-
tados mais observados nos doentes, aquando da monitorização dos programas, são: resposta clínica, utilização de serviços e estado 
de saúde.
Discussão: Cada país tem a sua própria forma de implementar a estratégia de gestão integrada da doença. O foco de atenção da 
prática clínica é o empoderamento dos doentes, particularmente através da promoção da auto-gestão. Os resultados clínicos e os de 
utilização dos serviços para além de serem os mais utilizados, são também, aqueles com maior impacto nos programas de gestão 
integrada da doença. 
conclusão: O sistema de saúde Português ainda enfrenta sérios desafios no tocante à coordenação e integração de cuidados dirigi-
dos à pessoa com doença crónica pelo que se sugere a atualização do programa.
Palavras-chave: Doença Crónica; Gestão de Caso; Gestão da Doença; Portugal; Prestação Integrada de Cuidados de Saúde.
INtrODUctION
 This article reviews findings from empirical evaluations 
of integrated disease management (IDM) programmes. The 
aim was to describe the integration levels, identify the most 
frequent interventions and outcomes and to synthesise 
knowledge about their implementation and performance. 
The article focuses on discussing the documented good 
practices in the international literature that could improve 
the IDM Portuguese model implemented in 2008.
 The article starts with a brief description of the most re-
cent developments and the context of IDM programmes; 
then the results of the literature search conducted in 2011 
are presented; and finally, the evidence is synthesised in or-
der to identify lessons that can be learned from international 
experiences.
context
 Chronic Disease Management (CDM) initiatives were 
originally developed in the United States (USA) in line with 
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the recommendation of Centers for Disease Control and 
Prevention, which state that the health care system should 
target diseases where effective public health preventive 
strategies exist, or are the subject of promising research.1 
CDM programmes aim to enable health care systems to be 
more supportive to patient-provider interactions,2 to improve 
overall health status and to reduce healthcare costs gene-
rated by chronic conditions.
 In 2012, the European Commission encouraged the 
replication of CDM models through an integrated care 
methodology known to improve the quality and accessibility 
of care to patients with a chronic condition (Opening speech 
on the European Year for Active Ageing and Solidarity be-
tween Generations, January 18, 2012 by Dalli J). In order 
to reduce deficiencies such as inadequate care transitions, 
inefficient information flow between different levels of care 
and low patient engagement,3 several European countries 
have, also, moved in that direction.4 In the case of Portugal, 
a national CDM project named Integrated Disease Manage-
ment (IDM) was launched in 2008, endorsed by the Ministry 
of Health. The introduction of the concept of integration was 
proposed as an alternative to fragmentation, duplication 
and inefficient use of resources in chronic disease manage-
ment.5
 The development of an IDM model became the main 
chronic disease strategy and decision-making tool in clinical 
management. It was perceived as a quality-driven approach 
to lead the reorganization of the Portuguese healthcare de-
livery structure6 and to rationalize service provision to im-
prove productivity, quality and price control.7,8
 In the context of great economic restraint this initiative 
increased the responsibility of patients (as self managers), 
providers (as clinical managers) and policy makers (as 
regulatory managers) involved in all phases of chronic di-
seases.6
 The Ministry of Health regulates health care delivery 
through a national online data base of patient’s records, in-
cluded in all IMD programmes, together with a set of clinical 
guidelines and auditing practices. This online system is an 
important tool for the follow-up of patients, the monitoring of 
quality of care, as well as the motoring of the epidemiologi-
cal evolution of the disease.6
 One of the key and most innovative components of this 
program was the introduction of a funding model, similar 
to ‘pay for performance’, in which providers receive a lump 
sum per patient if they achieve some performance targets. 
Expected results are risk sharing with providers, patient-
centred care practices, coordination of care, population risk 
stratification  and the implementation of a direct relationship 
between funding and quality and safety clinical parameters.6
Analytical Framework
 In many countries the coordination and integration of 
care remains a major challenges.3 In the literature there is 
no formal or consensual definition of integration of care. In 
non English-speaking countries the different concepts to 
describe integrated care are even more diverse.9 For the 
purpose of this review, Curry and Ham´s5 definition and 
classification was used: “integration is concerned with the 
processes of bringing organizations and professionals to-
gether, with the aim of improving outcomes for patients and 
service users through the delivery of integrated care”. 
 Several countries have adapted IDM programmes to 
their own health care systems.4 However, for the purpose of 
the present study, programmes were classified through the 
Chronic Care Model (CCM) conceptual framework. The six 
essential and interrelated elements of the CCM2 are: 
−	 Delivery System Design - A clear division of multi-
professional labour, separating the acute from the 
programmed care, in order to support process and 
structures through an effective patient care.
−	 Self-management Support - Collaborative strategies 
from education to support services based on self- 
-management principles, in a variety of formats that help 
patients and their families to acquire the skills to ma-
nage their condition. 
−	 Decision Support - Integration of evidence based clinical 
guidelines into practice, reminder systems, continuing 
medical education and inter-provider communications.
−	 Clinical Information Systems - Availability and compre-
hensiveness of clinical data during patient visits with re-
minder system to improve compliance with guidelines, 
performance measures and planning of care.
−	 Community Resources - Link with community based 
resources (hospitals, home care agencies, self help 
groups and senior homes).
−	 Health Care Organization - changes at the larger organi-
zational level, from structure, goals to values improved 
by a strong leadership. 
 Interventions described in the reviewed articles were 
also classified according to the Cochrane Effective Practice 
and Organization of Care (EPOC) taxonomy10 (Appendix 1), 
considering whether they were organizational, professional, 
regulatory or financial interventions. The item ‘patient inter-
ventions’ was also included in the present study to encom-
pass interventions related with the following: distribution of 
educational materials, education sessions, reminders, etc.
 Patient outcomes and other results were classified 
using the approach proposed by Zwar et al11: professional 
adherence to guidelines; patient adherence to treatment; 
patient health service use; patient physiological measure of 
disease; patient risk behavior; patient quality of life; patient 
health status; patient functional status; patient satisfaction. 
Two additional itens were added: ‘patient education’ and 
‘costs’.
MAtErIAL AND MEtHODs
 In 2011, a literature search in both Medline and Cochrane 
databases was undertaken to identify documents published 
on IDM, between January 2006 to end of June 2011. 
 We used keywords and Medical Subject Headings 
(MeSH) descriptors (Table 1) associated them with the 
following diseases: ‘chronic kidney failure, multiple 
sclerosis, obesity, pulmonary hypertension, diabetes 
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1 251 papers   
23 707 papers were automaticly  excluded  
when we cross search with chronic diseases 
24 958 papers were identified by searching Pubmed in  
MEDLINE and Cochrane , using textual terms and MeSH
headings  from 2006 to 2011. 
523 papers were 
duplicated502 papers  
337 papers included in this 
review
119 papers reviewed and 
classified into a single 
descriptor 
Exclusion Criteria
621 papers 
88 papers with Macro 
interventions
145 papers with Meso
interventions
104 papers with Micro 
interventions
284 papers were excluded because full-text was 
not available (to clarify any doubts) or were not in 
the selected language or not pertaining to disease 
management.
404 papers were 
excluded because 
they were in both 
research database 
27 papers did not report 
interventions, did not meet 
inclusion criteria  or wasn't 
collect
61 papers were 
included for 
detailed analysis 
1 025 papers were selected   
226 papers were excluded because title 
doesn’t pertain the study issue or abstracts  
were not available 
 
Figure 1 - Article selection process
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mellitus, asthma, chronic obstructive pulmonary disease, 
heart failure, coronary disease and arterial hypertension’. 
This selection corresponded to the health profile of Portugal 
at the time the IDM programme was developed in 2008 and 
to the results of a Delphi survey, conducted in 2009 by the 
Diretorate-General of Health to identify diseases which had 
a stronger impact in the health care system.12
 Inclusion criteria were: 1) publications in English, 
French, Spanish or Portuguese; 2) about diseases in hu-
man beings; 3) covering populations aged over 19 with one 
or more of the above-mentioned diseases.
  Articles were classified according to the three areas 
of coverage considered in the integration level category: 
‘macro’, ‘meso’ or ‘micro’. The review focused on evidence 
of lessons useful to informing policy at national level, and 
therefore, only the full text studies under the ‘macro’ dimen-
sion were included in the analysis. 
 We excluded documents consisting a study of one or 
two patients or which did not describe specific interventions.
Fig.1 details the steps in the identification of the articles and 
the number excluded at each stage.
 Data was extracted and introduced directly into an 
‘Excel’ database by a researcher and reviewed by a second 
one. All disagreements were resolved through discussion 
and consensus within the research team.
 All articles retrieved (N = 61) were grouped according to 
the CCM main focus using Wagner et al’s definition.2 Inter-
ventions were classified according to the EPOC taxonomy10 
and results were classified using the approach proposed by 
Zwar et al.11
 Overall results were discussed considering the Portu-
guese experience as a benchmark.
Table 2 - Number of studies per disease and percent with statistically significant improvements
Diseases N *
studies with 
documented 
outcomes‡
studies with 
statistically 
significant 
improvements§
% of Effective
 studies
Diabetes Mellitus 31 29 26  90%
Multiple Diseases 16 15 12  80%
Asthma   4   4   4 100%
Coronary disease   4   3   3 100%
Chronic obstructive pulmonary disease   3   3   2  67%
Heart failure   2   2   1  50%
Chronic kidney failure   1   1   1 100%
total 61 58 49  84%
* Number of studies included in the review per disease; ‡ Number of studies with documented outcomes per disease; § Number of studies with statistically significant improvements 
per disease.
Table 1 - Keywords and MeSH Terms used in the review 
Keywords and MesH terms PUbMEDN
cOcHrANE
N
Case management (MeSH) 102   39
Disease management (MeSH) 268 103
Chronic disease (MeSH)    0 429
Chronic disease management   80   16
Chronic disease self-management   16    8
Integrated disease management    5    3
Integrated chronic disease management   90    0
Integrated care   34   16
Integrated chronic disease    3    0
Integrated service management   39    0
637 614
tOtAL 1 251
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rEsULts
 The initial search identified 1 251 articles, of which 621 
were retained after an initial screening. After the exclusion 
of duplicates, this number fell to 337 articles. Articles on the 
‘Macro’ dimension (N = 88) were extracted by one investiga-
tor and checked by a second one. Only the 61 full text stu- 
dies under the ‘macro’ dimension were selected for analysis.
 Data was first characterized according to the main bibli-
ometric components. Programmes were then characterized 
according to their integration level, CCM elements, IDM in-
tervention using the EPOC taxonomy and finally according 
to their outcomes and effectiveness. 
 Supplementary material is available for more detailed 
information about the results (Synthesis of Results in 
Appendix 2).
bibliometric approach
 72% of total articles (n = 44) were identified in Med-
line (PubMed), 10% (n = 6) in Cochrane Database of Sys-
tematic Reviews and 18% (n = 11) were found in both of 
databases. All articles were in English; 51% had diabetes 
mellitus as the key disease-focus, followed by asthma and 
coronary disease (Table 2). 52% of the articles (n = 32) pre-
sented studies were conducted in the USA; other studies 
were from the Netherlands, the United Kingdom, Germany 
and Australia; none referred Portugal. 
 Classification identified 15 studies as ‘research support’, 
12 as ‘randomized controlled trials’, nine as ‘evaluation stu-
dies’, eight as comparative studies and 17 were classified in 
ca-tegories such as ‘review’ (n = 3), ‘controlled clinical trial’ 
(n = 3), ‘cohort study’ (n = 3), ‘quasi-experimental design’ 
(n = 2), ‘case study’ (n = 2), ‘multicenter study’ (n = 1) and 
‘meta-analysis’ (n = 1).
 ‘Population Health Management’ published six articles, ‘The 
American Journal of Managed Care’ four, ‘BMC Health Services 
Research’, ‘Diabetes care’ and ‘Medical Care’ three each.
Integration Level 
 Of the 61 articles classified as ‘macro’ interventions, 
25 were implemented by managed care organizations (19 
in USA and 2 in Germany), 22 by organized groups of fa- 
mily doctors, e.g. GP’s (6 in USA, 4 in the Netherlands and 
3 in UK and 3 in Australia); and the other 10 by hospitals 
specifically organized to respond to disease management 
challenges.
 Four articles described IDM programmes developed in 
the context of primary health care settings in collaboration 
with hospitals or managed care organizations; two in USA 
and one in the Netherlands and the United Kingdom.
ccM Elements 
 At least two or more CCM elements were described in 
56% of the studies (n = 34), with multiple combinations be-
tween them. In order to facilitate the analysis, the predomi-
nant CCM element was identified and articles were classi-
fied accordingly. Further categorization allowed to identify 
19 studies as self-management support, 15 as health care 
organization, 11 as delivery system design, 11 as decision 
support and 4 as clinical information system.
 As regards programme effectiveness, 58 studies pre-
sented improvements and in 49 of them these were con-
sidered statistically significant (Table 3). ‘Self-management 
support’ and ‘health care organizations’ were the two CCM 
elements with a higher number of IDM interventions and 
a higher number of studies reporting statistically significant 
improvements (16 of a total of 19 and 13 of a total of 14 
articles respectively). 
 As far as IDM programmes are concerned, 29 of them 
focused on Diabetes Mellitus, with 26 reporting statistically 
significant improvements (Table 2). There was only one 
study about obesity and it didn´t report any improvements.
IDM Interventions 
 From a total of 360 IDM interventions, the most frequent 
Table 3 - Number of EPOC interventions per CCM elements and percent with statistically significant improvements per disease
ccM Elements EPOcInterventions (N)*
studieswith 
documented 
outcomes (N)‡
studies with 
statistically 
significant 
improvements§
% of Effective 
studies
Clinical information system   10   4   4 100%
Decision support   39 10   8   80%
Delivery system design   93 10   7   70%
Health care organisation   86 14 13   93%
Self management support 128 19 16   84%
Community Resources     0   0   0   0
Not applicable     4   1   1 100%
total 360 58 49   84%
*Number of EPOC interventions identidied per CCM elementes; ‡ Number of studies with documented outcomes per CCM elementes; § Number of studies with statistically significant 
improvements per CCM elements.
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Table 4 - IDM Interventions classified according to the EPOC Taxonomy (N)
IDM Interventions by EPOc taxonomy N
Patient interventions
(N = 110)
Self management   26
Education sessions   25
Distribution of educational materials   23
Call back reminder notice   17
Motivational counselling   12
Brief intervention    7
Community programmes    3
Professional interventions 
(N = 105)
Audit and feedback  25
Distribution of educational materials  24
Educational meetings  21
Educational outreach visits 10
Reminders  10
Patient mediated interventions    9
Local consensus processes    3
Local opinion leaders    3
Other    1
Organisational interventions 
(N = 63)
Revision of professional roles    7
Clinical multidisciplinary teams   21
Formal integration of services    1  
Skill mix changes    3
Continuity of care   16
Communication and case discussion between distant health professionals    5
Other proveder oriented intervention    2
Presence and functioning of adequate mechanisms for dealing with patients’ 
suggestions and complaints    2
Other patient oriented intervention    6
Structural interventions  
(N = 58)
Changes to the setting/site of service delivery   13
Changes in physical structure, facilities and equipment    6
Changes in medical records systems   11
Changes in scope and nature of benefits and services   11
Presence and organisation of quality monitoring mechanisms   11
Ownership, accreditation, and affiliation status of hospitals and other facilities    1
Staff organization    5
Financial interventions 
(N = 19)
Fee-for-service    2
Capitation    2
Provider salaried service    1
Provider incentives    6
Institution incentives    1
Institution grant/allowance    1
Other (p4p)    4
Other Patient financial interventions    2
Regulatory interventions
 (N = 5)
Changes in medical liability    3
Management of patient complaints    2
total 360
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across all the disease groups were ‘patient interventions’ 
and ‘professional interventions’ (Table 4). 
 Among the former, the most frequent were:
- Self management (Supermarket tours and cooking 
classes, Training with life coach; Self-management 
group training program; Self-care initiatives led by care 
managers);
- Education sessions (Informal and formal education ses-
sions; Periodic educational mailings);
- Distribution of educational materials (Educational book/ 
manual or booklet; Videocassette; Training devices, ie 
blood pressure and glucose monitoring tools; Self-ma-
nagement guidelines; Action plan);
- Reminder notice (Reminders for medication compliance 
and vaccination; Reminder calls and text message; 
Telephone appointment reminders). 
 Among the latter, the most frequent interventions were: 
- Audit and feedback (Monitorization of indicators/stan-
dards of process and outcomes; Quality audit; Moni-
torization of guidelines accomplishment; Computerized/
Web based decision support system, Notification of 
gaps between patient-reported practice and guideline 
recommendations); 
- Distribution of educational materials (Therapeutic pro-
tocols; Clinical management guidelines; Guidance on 
implementing standards of care); 
- Educational meetings (Periodic fora, courses, work-
shops; Training for nurses and GP’s about chronic 
diseases and lifestyles; Conference calls with collabora-
tive leaders). 
Measuring intervention Outcomes 
 The most common health outcomes used to monitor the 
IDM programmes were (Table 5): 
- Physiological measures such as blood tests (HbA1c, 
cholesterol and triglyceride, micro-albuminuria, creati-
nine, proteinuria), blood pressure, nephropathy scree-
ning, eye and foot examination, immunizations; 
- Service use, evaluated through some organizational 
outcomes such as: length of stay, hospitalization rates, 
readmissions, visits to health offices or emergency de-
partment; and
- Patient health status, monitored by rates, scores and 
scales such as: anxiety level, depression score, vacci-
nation rate, the 10-year coronary heart disease risk and 
self-rated health self-care behaviour. 
DIscUssION
 The principal aim of this study was to identify documen-
ted good practices in the international literature which could 
inspire lessons to improve the Portuguese IDM model. 
Since the end of our literature search no new systematic 
reviews has been published which suggest some level of 
consensus about the effectiveness of disease management 
programmes.13,14
 The chronic diseases, which were included in this 
search (diabetes mellitus, asthma, coronary disease, etc.) 
reflect the ‘burden of disease’ of countries with the highest 
income and the most commonly managed at primary health 
care level.15
 We were able to identify several types of studies, using 
different methods and levels of rigour. The three most com-
mon types of evaluation designs applied to IDM program 
evaluation: were experimental designs, quasi-experimental 
designs, e.g. pre-post intervention studies with comparison 
group, and pre-experimental designs, e.g. pre-post studies 
without comparison group.16
Integration Level
 In general, findings show that countries developed their 
IDM strategies as part of a national or regional policy17 in or-
der to improve patient outcomes and reduce wastefulness.5
 A collaborative intervention between primary and se-
condary care was found only in four articles, which eviden-
ces that the interface between primary and secondary care 
still presents challenges in most countries.17 It also shows 
that IDM programmes, as discussed by other authors,15 
have their main focus on primary health care rather than 
on secondary health care as IDM programmes were mainly 
found to be developed within the context of managed care 
organizations or organized general or family practices.17
 The highest number of IDM programmes was reported 
in the USA.15 In 2005 UK established the National Health 
Service and Social Care Model, which based on the ‘pyra-
mid of care’ adapted from Kaiser Permanente, helped in-
troducing teams in primary care and creating a network of 
community providers.17 Other European countries such as 
Spain, Italy, Ireland and Portugal, progressively moved to-
wards the same approach.18
ccM Elements and IDM Interventions
 More than half of studies reported two or more compo-
nents from CCM and no country had all six components 
Table 5 - Analysis of the total number of outcomes reported in articles (N) 
Outcomes N
Patient physiological measure of disease 38
Patient service use 22
Patient health status 21
Patient risk behaviour 18
Costs 14
Patient education   8
Patient quality of life   8
Patient adherence to treatment   7
Professional adherence to guideline   4
Patient functional status   2  
Patient satisfaction   1
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been implemented.19 
 Better outcomes are associated with the presence and 
implementation of multiple CCM elements.20 Portugal is one 
of the few countries where the IDM program includes all six 
components at different levels of development.6 ‘Delivery 
System Design’ separates the acute from the programmed 
care by offering an effective patient care through treatment 
units and reference centres; ‘Decision Support’ and ‘Self-
management Support’ it integrate evidence-based clinical 
guidelines into professional practice and patients day life 
through a web base decision support system namely plat-
form ‘Dados de Saúde’.
 Programmes with ‘self-management support’, ‘clinical 
information system’, ‘delivery system design’ and ‘decision 
support’21 as predominant CCM elements, were considered 
effective. The Portuguese IDM program for the End Stage 
Renal Disease was evaluated as an efficient initiative of 
coordination22-24 in which the empowerment of patients, the 
use of evidence-based clinical practices, the prospective 
payment and the involvement of all the stakeholders con-
tributed to control health spending without compromising 
quality of care.7 
 In general, the methodology for implementing disease 
management and for measuring its effects, in the perspec-
tive of the CDM, is still in its infancy.16,25 The lack of quality 
data represents a major challenge for informed planning, 
health policies development, implementation and evalua-
tion, and programmes and community-based intervention 
oriented to patients with chronic diseases.1,21 The difficulty 
in assessing the effect of this model through experimental 
studies probably explains why such studies are rare21 and 
that no stronger evidence is available. 
 Even though most of studies reported improvements 
with statistical significance, evidence on the cost-effec-
tiveness of the CCM is still scarce, and more research is 
needed to understand the implications for practices, pay-
ers, and patients.20 There is also little quantitative evidence 
documenting the relative importance1 and effectiveness25 
of each component separately. Further research is also re-
quired to explore the most effective combinations of CCM 
elements and the different implementation processes in or-
der to increase the likelihood of improvements.20,26
 Despite the scarcity of evidence regarding the effec-
tiveness of IDM intervention in general, there is a growing 
body of studies showing that when compared to standard 
health care, self-management approaches provide benefits 
to participants, particularly in terms of knowledge, impact 
of self-management behaviours and health status.27 The 
Care Continuum Alliance defends that the successful self-
management of a chronic disease can slow down disease 
progression, improve quality of life and save money.16 
 Other authors4 conclude that most disease manage-
ment programmes give more emphasis to the compliance 
with medical prescriptions than to other self-management 
components, such as the involvement of the family and 
community, limiting self-management interventions in fa-
vour of self-monitoring of some clinical parameters and life-
style changes.
 Educational sessions and distribution of educational 
material seem to be highly valued interventions by patients 
and professionals. The empowerment of patients and the 
increase of their knowledge are sine qua non conditions in 
all disease management programmes; but to have patients 
better informed, proactive and more involved in decision-
making processes, the personalization of education ses-
sions and materials is needed, as well as continuing access 
to relevant information.4
 In Portugal as in other European countries, the develop-
ment of a patient portal is under implementation and some 
services that improved CDM and continuity of care, are al-
ready offered.28
 IDM programmes that incorporate provider education, 
feedback and reminders, are associated with improvements 
in disease control.5 The production, distribution and impact 
of guidelines vary among countries, for instance, in Eng-
land, for instance, the Health Department NICE produces 
evidence-based guidelines and tools,25 and in the USA, 
most activities in CDM are found in health plans, such as 
those implemented by the National Committee for Quality 
Assurance, Kaiser Permanente and similar organizations.25 
Portugal, like other European countries, has a tradition of 
regulating health care at central level, through guidelines, 
clinical auditing and inspections and believe that under the 
IDM model, health professionals become more involved in 
cost-effective guidance and in clinical governance.6
 The CCM provides a useful conceptual framework for 
understanding some of the elements considered essential 
for the management of chronic disease and the interplay 
between its elements.11 But when it comes to their effec-
tiveness show that interventions applied to diabetes and 
coronary disease tend to concentrate the highest number of 
statistically significant improvements.21
 While the literature and the findings of the present study 
identified some evidence of improvements in patient out-
comes, an objective evaluation requires to consider the 
health care context, whether it is of public or private provi-
sion, and the beliefs and attitudes of the patients.26
Measuring Intervention Outcomes 
 Quantitative data about ‘physiological measure of di-
sease’, ‘service use’, ‘health status’ and ‘risk behavior’, 
were more frequently used than qualitative outcomes like 
‘satisfaction’, ‘adherence to treatment’ and ‘quality of life’.
 There is evidence that clinical outcomes are easier to 
measure through standard tests and procedures, e.g. annu-
al retinal examination or screening of diabetic nephropathy, 
which explains their frequent use.16,21,29 Service utilization 
is commonly measured by calculating inpatient admission 
rate and emergency room attendance.16,21,29 A review of li-
terature in 2006 concluded that there is some evidence that 
disease management programmes can reduce unplanned 
admissions.5
 A survey conducted in ten European countries in 2010 
shows that clinical parameters, hospital admissions and life-
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style changes are the most commonly used progress indi-
cators in terms of implementation of disease programmes.4
We identified only one programme, the Netherlands, that 
monitors changes on patient satisfaction, even though, this 
is widely recognized, as an important dimension of health 
care.4,9 In Portugal all patients included in the national IDM 
programme periodically report their satisfaction level.6
 Different countries are at different stages in the imple-
mentation and development IDM programmes. Countries 
also use different types of intervention, monitor results with 
different follow up periods and even use diverse concepts 
and models to refer to their approach to manage chronic 
diseases.5 As a result, good practices are not easily repli-
cated and different measures of performance and impact 
evaluation are not standardized.11,16
cONcLUsION 
 The present article provides insights on the response of 
different countries’ to the challenges of CDM, by analyzing 
different interventions of IDM programmes implemented at 
the political, management and health care levels. 
 In the case of Portugal, IDM programmes incorporate 
all the CCM elements, each at different stages of develop-
ment. Like other European countries,8 Portugal also develo- 
ped incentives to manage chronic diseases and hence 
reduce the fragmentation of care and improve cost control 
and quality.6,7
 This review highlights the CCM elements and EPOC 
interventions related with self-management support and 
patient interventions, which are the less developed compo-
nents in Portugal. The Portuguese experience is more fo-
cused in professional interventions, such as monitorization 
of standards, guidelines adoption, quality audit, financial 
interventions (payment for performance) and organisational 
interventions (formal integration of services with the identifi-
cation of a chronic disease reference network). In the near 
future more attention should be given to the patient/com-
munity empowerment.
 There is little robust evidence of what works or not at 
IDM, particularly in the CCM,20 and how health care sys-
tems should be organized. This appears to be country 
and context specific: countries have their own institutional 
arrangements, economic conditions, level of political 
commitment, planning tradition, as well as capacity and 
dynamics in the relationship among the numerous stake-
holders,1,19,21 no standard indicators are used to measure 
outcomes,5,11,16 and there is no monitoring culture.30,31
 In Portugal the most frequently used mechanisms to 
measure outcomes are ‘physiological measures’ and ‘ser-
vice use’. The Portuguese programme is one of the few 
that’s applies initiatives to measure ‘patient satisfaction’ 
systematically but others parameters could also be incorpo-
rated such as ‘health status’ and ‘risk behaviour’.
 It remains a challenge to draw overall conclusions, be-
cause of the heterogeneity of disease management inter-
ventions29 and of the population selection criteria to evalu-
ate chronic care management programmes.16 Conclusions 
of the present literature search must be treated with cau-
tion, avoiding generalizations and judgements based on 
the analysis of interventions in a single field or in a single 
country.19 To better understand whether policy reforms in 
the management of chronic diseases deliver the promi-
sing results, more attention should be paid to monitoring 
the design, implementation and outcomes of each interven-
tion.30-32
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